News

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...
The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...
Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.
The best high-yield dividend stocks we recommend are The Brookfield Renewable Partners L.P., Pfizer, and Healthpeak ...
Pfizer's PFE non-COVID operational revenues improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and ...
The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.
The project is starting with a $240,000 grant from Alumbra, a foundation established by billionaire Christy Walton ...
A group of volunteers this week spent time hanging drywall at a Habitat for Humanity home on West Buttonwood Street.
Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
If a company files for Chapter 7 bankruptcy, that means it's heading for liquidation, in which assets are sold off to pay creditors.
Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...